Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ea200c15bbfe5bbb2493b6419fa853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bef96a52ca9eaf6230a857ba74af9a1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
filingDate |
2000-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea4584ea81cdb44e17902bdd78ab395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633708cd10ef1897f0f073c749d927a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf1ff9efb7800da2edd67388fb0219a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_286119161dea9f0a0e986eaa14fe8734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20245a2adb942b064d60e1480a929289 |
publicationDate |
2002-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-0105490-A2 |
titleOfInvention |
Epitopes and mimotopes, antagonists and therapeutic uses derived from the C-epilon-3 or C-epilon-4 domain of IgE |
abstract |
The present invention provides medicinal products for the treatment, prevention or correction of allergic diseases. Preferred drugs are senizolated peptides that contain epitopes or isotopes of the Ce3 and Ce4 domains of IgE. These regions can be the target of both active and passive immunoprophylaxis or immunotherapy. The present invention is further useful in the preparation of drugs. The present invention includes ligands, preferably monoclonal antibodies, which are capable of binding to regions of the IgE according to the present invention, and which are useful in the therapeutic agent as passive immunotherapy or in immunoprophylaxis |
priorityDate |
1999-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |